• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
POH
Click for more information
0.00% 0.0¢

PROGRESS 2023-2 TRUST - Announcements

Market Cap $0  ! watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
POHPOH Licences TPM Platform to Indian Pharmaceutical CompanyPRICE SENSITIVE30/10/12
POHJune 2012 Half Yearly Report and Financial ReportPRICE SENSITIVE20/08/12
POHNeura Therapeutik Appointed as US Strategic AdvisorsPRICE SENSITIVE01/08/12
POHPOH Further Refinements to Oxycodone Patch DesignPRICE SENSITIVE05/06/12
POHPOH adds David Jones as retail partner for Elixia productsPRICE SENSITIVE08/05/12
POHPOH Signs License Agreement with Intas PharmaceuticalsPRICE SENSITIVE04/04/12
POHKorean Distribution Agreement for BioElixiaPRICE SENSITIVE15/03/12
POHPOH signs Agreement with Japanese Pharmaceutical CompanyPRICE SENSITIVE05/03/12
POHDecember 2011 Preliminary Final and Audited Financial ReportPRICE SENSITIVE21/02/12
POHDelivery of Further Positive Oxycodone Patch Trial ResultsPRICE SENSITIVE15/02/12
POHPivotal TPM-oxycodone Patch Trials BeginPRICE SENSITIVE21/11/11
POHPhosphagenics Licenses Diclofenac Gel for Indian MarketPRICE SENSITIVE02/11/11
POHSuccessful $24.1m Capital Raising and $3m SPPPRICE SENSITIVE21/10/11
POHTrading haltPRICE SENSITIVE19/10/11
POHPOH to Proceed with Twice Weekly Oxycodone Patch DevelopmentPRICE SENSITIVE03/10/11
POHPOH Ready to Commence Pivital Oxycodone Clinical TrialsPRICE SENSITIVE19/09/11
POHPOH signs Development Deal with Global Cosmetic CompanyPRICE SENSITIVE14/09/11
POHJune 2011 Half Yearly Appendix 4D and Financial ReportPRICE SENSITIVE26/08/11
POHNew National Stockist for ELIXIA Personal Care Product RangePRICE SENSITIVE23/08/11
PGL +Progen Subsidiary Secures New Manufacturing ContractsPRICE SENSITIVE20/07/11
POHMajor Distribution Agreement for Asia for ELIXIA ProductsPRICE SENSITIVE06/07/11
POHElixia range of Personal Care Products - UpdatePRICE SENSITIVE28/06/11
POHPOH and 3M Collaborate to Improve Oxycodone Patch 5 FoldPRICE SENSITIVE23/05/11
POHLaunch of BodyShaper Cellulite Contour CremePRICE SENSITIVE17/05/11
POHPhosphagenics moves into lucrative hair marketPRICE SENSITIVE20/04/11
POHPhosphagenics to Launch New Cellulite CosmeticsPRICE SENSITIVE11/04/11
POHPhosphagenics Collaboration To Develop Anti-acne DrugPRICE SENSITIVE04/04/11
POHEquity RaisingPRICE SENSITIVE14/03/11
POHTrading HaltPRICE SENSITIVE10/03/11
POHPhosphagenics to Partner Agricultural Company for ANZ marketPRICE SENSITIVE03/03/11
POHAppendix 4E December 2010 Preliminary Final ReportPRICE SENSITIVE25/02/11
POHPhosphagenics collaboration to develop psoriasis drugPRICE SENSITIVE07/02/11
POHPOH and Metier Tribeca LLC expand cosmetics product rangePRICE SENSITIVE27/01/11
POHPhosphagenics Collaborates With 3M To Develop Pain PatchPRICE SENSITIVE16/11/10
CZD +Anti-fat Peptide Patch progresses - product sales early 2011PRICE SENSITIVE19/10/10
CZD +Calzada signs Licensing deal with PhosphagenicsPRICE SENSITIVE19/10/10
POHPreparation- pain patch manufacturing after positive resultsPRICE SENSITIVE13/10/10
CZD +PHOSPHAGENICS EXERCISES OPTION TO LICENCE AOD9604PRICE SENSITIVE02/09/10
CZD +Phosphagenics - Calzada - Exercise of optionPRICE SENSITIVE02/09/10
POHJune 2010 Half Yearly Appendix 4D and Financial ReportPRICE SENSITIVE13/08/10
POHAppointment of Joint CEO - Dr Esra OgruPRICE SENSITIVE29/04/10
POHPOH Global Agreement with Novartis Animal HealthPRICE SENSITIVE31/03/10
POHPhosphagenics and Quigley Corp form JV for OTC ProductsPRICE SENSITIVE23/03/10
POHResponse to an ASX Price QueryPRICE SENSITIVE17/03/10
POHDecember 2009 Appendix 4E and Statutory Financial ReportPRICE SENSITIVE19/02/10
POHPhosphagenics Launches Australian Skincare ProductsPRICE SENSITIVE03/02/10
POHPositive Results Phase 1B Study Transdermal Oxycodone PatchPRICE SENSITIVE01/02/10
POHInsulin Patch On Track for Clinical TrialsPRICE SENSITIVE17/12/09
POHMetabolic Syndrome Trial ResultsPRICE SENSITIVE15/12/09
POHOxycodone Patch - Initiation of a Phase 1B Clinical TrialPRICE SENSITIVE02/12/09
POHTransdermal Oxycodone Matrix Patch Phase 1 TrialPRICE SENSITIVE15/09/09
POHPOH to Commence Phase 2-3 Topical Diclofenac TrialPRICE SENSITIVE09/09/09
POHJune 2009 Half Yearly Appendix 4D and Financial ReportPRICE SENSITIVE24/08/09
POHUnderwritten Share Purchase PlanPRICE SENSITIVE13/08/09
POHPOH-Metier Tribeca USA cosmetics launch Le Metier de BeautePRICE SENSITIVE20/07/09
POHSuccessful Completion Phase 1 Clincial using TPM/OxycodonePRICE SENSITIVE29/06/09
POHCompletion - Transdermal Patch Prototypes - OxycodonePRICE SENSITIVE29/05/09
POHRetinoic Acid - Two-staged Phase 1 Clinical TrialPRICE SENSITIVE30/04/09
POHSuccessful Completion Phase 1 Diclofenac StudyPRICE SENSITIVE24/02/09
POHAppendix 4E Preliminary Final Report inc Financial ReportPRICE SENSITIVE18/02/09
POHAcquired Intangible Asset Valuation ReviewPRICE SENSITIVE28/01/09
POHInsulin Trial on Type 1 Diabetic Patients CompletedPRICE SENSITIVE06/01/09
POHPositive Phase 1 Clinical Trial for Transdermal LidocainePRICE SENSITIVE08/12/08
POHPOH Licences TPM Platform to Indian Pharmaceutical Company
30/10/12PRICE SENSITIVE
POHJune 2012 Half Yearly Report and Financial Report
20/08/12PRICE SENSITIVE
POHNeura Therapeutik Appointed as US Strategic Advisors
01/08/12PRICE SENSITIVE
POHPOH Further Refinements to Oxycodone Patch Design
05/06/12PRICE SENSITIVE
POHPOH adds David Jones as retail partner for Elixia products
08/05/12PRICE SENSITIVE
POHPOH Signs License Agreement with Intas Pharmaceuticals
04/04/12PRICE SENSITIVE
POHKorean Distribution Agreement for BioElixia
15/03/12PRICE SENSITIVE
POHPOH signs Agreement with Japanese Pharmaceutical Company
05/03/12PRICE SENSITIVE
POHDecember 2011 Preliminary Final and Audited Financial Report
21/02/12PRICE SENSITIVE
POHDelivery of Further Positive Oxycodone Patch Trial Results
15/02/12PRICE SENSITIVE
POHPivotal TPM-oxycodone Patch Trials Begin
21/11/11PRICE SENSITIVE
POHPhosphagenics Licenses Diclofenac Gel for Indian Market
02/11/11PRICE SENSITIVE
POHSuccessful $24.1m Capital Raising and $3m SPP
21/10/11PRICE SENSITIVE
POHTrading halt
19/10/11PRICE SENSITIVE
POHPOH to Proceed with Twice Weekly Oxycodone Patch Development
03/10/11PRICE SENSITIVE
POHPOH Ready to Commence Pivital Oxycodone Clinical Trials
19/09/11PRICE SENSITIVE
POHPOH signs Development Deal with Global Cosmetic Company
14/09/11PRICE SENSITIVE
POHJune 2011 Half Yearly Appendix 4D and Financial Report
26/08/11PRICE SENSITIVE
POHNew National Stockist for ELIXIA Personal Care Product Range
23/08/11PRICE SENSITIVE
PGL +Progen Subsidiary Secures New Manufacturing Contracts
20/07/11PRICE SENSITIVE
POHMajor Distribution Agreement for Asia for ELIXIA Products
06/07/11PRICE SENSITIVE
POHElixia range of Personal Care Products - Update
28/06/11PRICE SENSITIVE
POHPOH and 3M Collaborate to Improve Oxycodone Patch 5 Fold
23/05/11PRICE SENSITIVE
POHLaunch of BodyShaper Cellulite Contour Creme
17/05/11PRICE SENSITIVE
POHPhosphagenics moves into lucrative hair market
20/04/11PRICE SENSITIVE
POHPhosphagenics to Launch New Cellulite Cosmetics
11/04/11PRICE SENSITIVE
POHPhosphagenics Collaboration To Develop Anti-acne Drug
04/04/11PRICE SENSITIVE
POHEquity Raising
14/03/11PRICE SENSITIVE
POHTrading Halt
10/03/11PRICE SENSITIVE
POHPhosphagenics to Partner Agricultural Company for ANZ market
03/03/11PRICE SENSITIVE
POHAppendix 4E December 2010 Preliminary Final Report
25/02/11PRICE SENSITIVE
POHPhosphagenics collaboration to develop psoriasis drug
07/02/11PRICE SENSITIVE
POHPOH and Metier Tribeca LLC expand cosmetics product range
27/01/11PRICE SENSITIVE
POHPhosphagenics Collaborates With 3M To Develop Pain Patch
16/11/10PRICE SENSITIVE
CZD +Anti-fat Peptide Patch progresses - product sales early 2011
19/10/10PRICE SENSITIVE
CZD +Calzada signs Licensing deal with Phosphagenics
19/10/10PRICE SENSITIVE
POHPreparation- pain patch manufacturing after positive results
13/10/10PRICE SENSITIVE
CZD +PHOSPHAGENICS EXERCISES OPTION TO LICENCE AOD9604
02/09/10PRICE SENSITIVE
CZD +Phosphagenics - Calzada - Exercise of option
02/09/10PRICE SENSITIVE
POHJune 2010 Half Yearly Appendix 4D and Financial Report
13/08/10PRICE SENSITIVE
POHAppointment of Joint CEO - Dr Esra Ogru
29/04/10PRICE SENSITIVE
POHPOH Global Agreement with Novartis Animal Health
31/03/10PRICE SENSITIVE
POHPhosphagenics and Quigley Corp form JV for OTC Products
23/03/10PRICE SENSITIVE
POHResponse to an ASX Price Query
17/03/10PRICE SENSITIVE
POHDecember 2009 Appendix 4E and Statutory Financial Report
19/02/10PRICE SENSITIVE
POHPhosphagenics Launches Australian Skincare Products
03/02/10PRICE SENSITIVE
POHPositive Results Phase 1B Study Transdermal Oxycodone Patch
01/02/10PRICE SENSITIVE
POHInsulin Patch On Track for Clinical Trials
17/12/09PRICE SENSITIVE
POHMetabolic Syndrome Trial Results
15/12/09PRICE SENSITIVE
POHOxycodone Patch - Initiation of a Phase 1B Clinical Trial
02/12/09PRICE SENSITIVE
POHTransdermal Oxycodone Matrix Patch Phase 1 Trial
15/09/09PRICE SENSITIVE
POHPOH to Commence Phase 2-3 Topical Diclofenac Trial
09/09/09PRICE SENSITIVE
POHJune 2009 Half Yearly Appendix 4D and Financial Report
24/08/09PRICE SENSITIVE
POHUnderwritten Share Purchase Plan
13/08/09PRICE SENSITIVE
POHPOH-Metier Tribeca USA cosmetics launch Le Metier de Beaute
20/07/09PRICE SENSITIVE
POHSuccessful Completion Phase 1 Clincial using TPM/Oxycodone
29/06/09PRICE SENSITIVE
POHCompletion - Transdermal Patch Prototypes - Oxycodone
29/05/09PRICE SENSITIVE
POHRetinoic Acid - Two-staged Phase 1 Clinical Trial
30/04/09PRICE SENSITIVE
POHSuccessful Completion Phase 1 Diclofenac Study
24/02/09PRICE SENSITIVE
POHAppendix 4E Preliminary Final Report inc Financial Report
18/02/09PRICE SENSITIVE
POHAcquired Intangible Asset Valuation Review
28/01/09PRICE SENSITIVE
POHInsulin Trial on Type 1 Diabetic Patients Completed
06/01/09PRICE SENSITIVE
POHPositive Phase 1 Clinical Trial for Transdermal Lidocaine
08/12/08PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.0¢ 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
POH (ASX) Chart

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Resolute shares bounce back as second payment made to Mali government to secure workers' release Resolute Mining Ltd has told investors that a second payment has been made to the Mali government following the detention of three employees
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.